<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-K1ADMDU5</identifier><date>2000</date><creator>Červek, Jožica</creator><relation>documents/doc/K/URN_NBN_SI_doc-K1ADMDU5_001.pdf</relation><relation>documents/doc/K/URN_NBN_SI_doc-K1ADMDU5_001.txt</relation><format format_type="issue">1</format><format format_type="volume">4</format><format format_type="type">article</format><format format_type="extent">str. 22-23</format><identifier identifier_type="COBISSID">11777753</identifier><identifier identifier_type="ISSN">1408-1741</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-K1ADMDU5</identifier><language>slv</language><publisher>Onkološki inštitut Ljubljana</publisher><source>Onkologija (Ljubljana)</source><rights>BY</rights><subject language_type_id="eng">Antineoplastic agents</subject><subject language_type_id="eng">Bone neoplasms</subject><subject language_type_id="eng">Diphosphonates</subject><subject language_type_id="eng">Drug therapy</subject><subject language_type_id="eng">Hormones</subject><subject language_type_id="slv">kosti</subject><subject language_type_id="slv">metastaze</subject><subject language_type_id="slv">onkologija</subject><subject language_type_id="eng">Secondary</subject><subject language_type_id="eng">therapy</subject><subject language_type_id="slv">zdravljenje</subject><title>Sistemsko zdravljenje kostnih metastaz</title></Record>